Showing results (1791-1800 of 2,464) with videos related to
Sort By:
Pageof 247
Molecular Pharmacology|October 23, 2002
Quantitation of the P2Y(1) receptor with a high affinity radiolabeled antagonistGary L Waldo, James Corbitt, José L Boyer, et al.World Journal of Clinical Oncology|September 3, 2025
GPR81 nuclear transportation is critical for cancer growth and progression in lung and other solid cancersLiBang Yang, Thomas Kono, Adam Gilbertsen, et al.Journal of Clinical Immunology|April 12, 2005
Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067Ronald D'Amico, Yijun Yang, Donna Mildvan, et al.Journal of Pediatric Hematology/Oncology Nursing|July 6, 2022
Addressing Schooling in Children With Cancer-It's Everybody's Job, So It's Nobody's Job: An Explanatory Mixed-Methods EvaluationClifton P Thornton, Sydney Henegan, Lisa B Carey, et al.Nucleosides, Nucleotides & Nucleic Acids|October 21, 2003
Design and synthesis of A3 adenosine receptor ligands, 3'-fluoro analogues of Cl-IB-MECAHea Ok Kim, Moo Hong Lim, Jae Gyu Park, et al.Journal of Cellular Physiology|June 11, 2011
CF102 an A3 adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liverS Cohen, S M Stemmer, G Zozulya, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 7, 2007
Ras pathway activation in malignant mesotheliomaManish R Patel, Blake A Jacobson, Arpita De, et al.Nucleosides, Nucleotides & Nucleic Acids|December 11, 2007
Synthesis of N6-substituted 3'-ureidoadenosine derivatives as highly potent agonists at the mutant A3 adenosine receptorLak Shin Jeong, Seung Ah Choe, Ae Yil Kim, et al.Protein Expression and Purification|June 1, 1993
Expression, purification and characterization of multigram amounts of a recombinant hybrid HV1-HV2 hirudin variant expressed in Saccharomyces cerevisiaeE D Lehman, J G Joyce, F J Bailey, et al.Bioorganic & Medicinal Chemistry|October 7, 2004
Nucleotide analogues containing 2-oxa-bicyclo[2.2.1]heptane and l-alpha-threofuranosyl ring systems: interactions with P2Y receptorsMichihiro Ohno, Stefano Costanzi, Hak Sung Kim, et al.Pageof 247